Efficacy and safety of lazertinib 240 mg as the clinical dose in patients with EGFR T790M mutant NSCLC: Data from a phase I/II study.
暂无分享,去创建一个
M. Ahn | E. Cho | Dong-Wan Kim | B. Cho | Sang-We Kim | Y. Min | Ji-Youn Han | J. S. Lee | Jong-Mu Sun | K. Lee | Gyeong-Won Lee | S. Shin | Yun-Gyoo Lee | S. Chun | H. M. Byun | M. Hong | B. Shim | S. S. Lee | J. Kim | Jin Soo Kim